STEVEN MANNING: Open Payments
NPI 1932367521 · WILLIAMSTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 21 payments from 11 companies in 2025. Trend: 2023 $118 · 2024 $114 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| ABBVIE INC. | 3 | $50 |
| Corcept Therapeutics | 2 | $48 |
| PFIZER INC. | 2 | $47 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Novo Nordisk Inc | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Dexcom, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 2 | $18 |
Products named: WATCHMAN Access System, REXULTI, VRAYLAR, Korlym, ELIQUIS, Ozempic, GEMTESA, FANAPT.
Industry payments across NC — which companies pay providers there.
